Prevalence and management of hypertension in Type 1 diabetes mellitus in Europe: The Eurodiab IDDM Complications Study

Diabetic Medicine

Volumn 16, Issue 1, 1999, Pages 41-48

  Collado Mesa, F ^a   Colhoun, H M ^b   Stevens, L K ^b   Boavida, J ^c   Ferriss, J B ^d   Karamanos, B ^e   Kempler, P ^f   Michel, G ^h   Roglic, G ^g   Fuller, J H ^b  

^a INSTITUTO NACIONAL DE ENDOCRINOLOGÍA   (Cuba)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c Portuguese Diabetes Association   (Portugal)

^d University College Cork and INFANT Centre   (Ireland)

^e HIPPOKRATION HOSPITAL   (Greece)

^f SEMMELWEIS UNIVERSITY   (Hungary)

^g University of Zagreb   (Croatia)

^h University of London ^*

Author keywords

Arterial hypertension; Awareness; Control; Prevalence; Treatment; Type 1 diabetes mellitus

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INSULIN; THIAZIDE DIURETIC AGENT;

ADOLESCENT; ADULT; ARTICLE; AWARENESS; BLOOD PRESSURE REGULATION; DISEASE CONTROL; DISEASE DURATION; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; PREVALENCE; TREATMENT OUTCOME; TREATMENT PLANNING; UNITED KINGDOM;

EID: 0033015648     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.1999.00007.x     Document Type: Article

References (27)

1. 1 Fuller JH, Stevens LK, Wang S. Epidemiology of hypertension in diabetic patients. J Cardiovasc Pharmacol 1996; 28: S1-S5.
2. 2 Selby JV, Fitzsimmons SC, Newman JM, Katz PP, Sepe S, Showstack J. The natural history and epidemiology of diabetic nephropathy. JAMA 1990; 263: 1954-1960.
3. 3 Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Arch Intern Med 1989; 149: 2427-2432.
4. 4 Janka HU, Warram JH, Rand LI, Krolewski AS. Risk factors for progression of background retinopathy in long-standing IDDM. Diabetes 1989; 38: 460-464.
5. 5 ADA Consensus Panel. Treatment of hypertension in diabetes. Diabetes Care 1993; 16: 1394-1401.
6. 6 The National High Blood Pressure Education Program Working Group. The National High Blood Pressure Education Program Working Group report on hypertension in diabetes. Hypertension 1994; 23: 145-160.
7. 7 European IDDM, Policy Group. Consensus Guidelines for the Management of Insulin-Dependent (Type I) Diabetes. Diabetic Med 1993; 10: 990-1005.
8. 8 Krans HMJ, Porta M, Keen H, Staehr Johansen K, eds. Diabetes care and research in Europe: the St Vincent Declaration action programme. Implementation document, 2nd edn. 1995; Guidelines on cardiovascular disease and stroke.
9. 9 The Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-2446.
10. 10 Wilber JA, Barrow JG. Hypertension: a community problem. Am J Med 1972; 52: 653-663.
11. 11 Burt VL, Cutler JA, Higgins M et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the Health Examination Surveys, 1960-91. Hypertension 1995; 26: 60-69.
12. 12. The EURODIAB IDDM Complications Study Group. Microvascular and acute complications in insulin dependent diabetes mellitus: the EURODIAB IDDM Complications Study. Diabetologia 1994; 37: 278-285.
13. 13 Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie A, The EURODIAB IDDM Complications Study Group. Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study. Diabetologia 1995; 38: 437-444.
14. 14 Colhoun HM, Dong W, Poulter NR. Blood pressure screening management and control in England: results from the Health Survey for England 1994. J Hypertens 1998; 16: 747-752.
15. 15 Marchant B, Umachandran V, Stevenson R, Kopelman PG, Timmis AD. Silent myocardial ischemia: role of subclinical neuropathy in patients with and without diabetes. J Am Coll Cardiol 1993; 22: 1433-1437.
16. 16 Paillole C, Ruiz J, Juliard JM, Leblanc H, Gourgon R, Passa P. Detection of coronary artery disease in diabetic patients. Diabetologia 1995; 38: 726-731.
17. 17 Fahey TP, Lancaster T. The detection and management of hypertension in the elderly in Northamptonshire. J Public Health Med 1995; 17: 57-62.
18. 18 Chau NP, Bauducea B, Vilar J, Gautier D. Relationship between autonomic dysfunction and BP variability in subjects with diabetes mellitus. J Hum Hypertens 1993; 7: 251-255.
19. 19 European NIDDM Policy Group. A Desktop Guide for the Management of Non-insulin-dependent Diabetes Mellitus (NIDDM). Brussels: International Diabetes Federation, 1989: 19.
20. 20 Curb JD, Pressel SL, Cutler JA et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 1996; 276: 1886-1892.
21. 21 The Hypertension Detection and Follow-up Program Cooperative Group. Mortality findings for stepped-care and referred-care participants in the hypertension detection and follow-up program, stratified by other risk factors. Prev Med 1985; 14: 312-335.
22. 22 Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood-pressure lowering and low dose aspirin in patients with hypertension: prinicipal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755-1762.
23. 23 Parving H, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 1987; 294: 1443-1447.
24. 24 Mogensen CE. The effect of blood pressure intervention of renal function in insulin dependent diabetes. Diabete Metab 1989; 15: 343-351.
25. 25 Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, and the Collaborative Study Group. The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-1462.
26. 26 The EUCLID Study Group. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 1997; 349: 1787-1792.
27. 27 Chaturvedi N, Sjolie A, Stephenson JM et al. and the EUCLID Study Group. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. Lancet 1998; 351: 28-31.